 | • レポートコード：MRC2-11QY11070 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は生物学的治療のグローバル市場について調査・分析したレポートです。種類別（ワクチン、血液製剤、アレルゲン抽出物、ヒト細胞・組織、遺伝子治療、タンパク質、細胞治療、異種移植製品）市場規模、用途別（関節リウマチ、貧血、がん、糖尿病、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別生物学的治療の競争状況、市場シェア ・世界の生物学的治療市場：種類別市場規模 2015年-2020年（ワクチン、血液製剤、アレルゲン抽出物、ヒト細胞・組織、遺伝子治療、タンパク質、細胞治療、異種移植製品） ・世界の生物学的治療市場：種類別市場規模予測 2021年-2026年（ワクチン、血液製剤、アレルゲン抽出物、ヒト細胞・組織、遺伝子治療、タンパク質、細胞治療、異種移植製品） ・世界の生物学的治療市場：用途別市場規模 2015年-2020年（関節リウマチ、貧血、がん、糖尿病、その他） ・世界の生物学的治療市場：用途別市場規模予測 2021年-2026年（関節リウマチ、貧血、がん、糖尿病、その他） ・北米の生物学的治療市場分析：米国、カナダ ・ヨーロッパの生物学的治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの生物学的治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の生物学的治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの生物学的治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Novartis Global、AstraZeneca、Merck、GlaxoSmithKline、Aurobindo Pharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
First and foremost, increasing reimbursement for biologics is predicted to positively influence the biologic therapeutics market in the upcoming years. Medical insurance companies and state-run insurance schemes are increasingly accepting claims against biologic therapeutics. Biologic therapeutics are gaining popularity due the efficacy of biologic therapeutic drugs and fewer side effects than chemical-based drugs. This is because biologic drugs are obtained from natural sources such as plants, or even living components such as cells and tissues of animals, microorganisms, or humans. These fragments are further treated to make therapeutic products such as blood components, vaccines, and recombinant therapeutic proteins.
Market Analysis and Insights: Global Biologic Therapeutics Market
The global Biologic Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Biologic Therapeutics Scope and Market Size
Biologic Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biologic Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Novartis Global
AstraZeneca
Merck
GlaxoSmithKline
Aurobindo Pharma
…
Market segment by Type, the product can be split into
Vaccines
Blood Products
Allergenic Extracts
Human Cells and Tissues
Gene Therapies
Protein
Cellular Therapies
Xenotransplantation Products
Market segment by Application, split into
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biologic Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Biologic Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Vaccines
1.4.3 Blood Products
1.4.4 Allergenic Extracts
1.4.5 Human Cells and Tissues
1.4.6 Gene Therapies
1.4.7 Protein
1.4.8 Cellular Therapies
1.4.9 Xenotransplantation Products
1.5 Market by Application
1.5.1 Global Biologic Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Rheumatoid Arthritis
1.5.3 Anemia
1.5.4 Cancer
1.5.5 Diabetes
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Biologic Therapeutics Market Perspective (2015-2026)
2.2 Global Biologic Therapeutics Growth Trends by Regions
2.2.1 Biologic Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biologic Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Biologic Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biologic Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Biologic Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Biologic Therapeutics Players by Market Size
3.1.1 Global Top Biologic Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Biologic Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Biologic Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biologic Therapeutics Market Concentration Ratio
3.2.1 Global Biologic Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biologic Therapeutics Revenue in 2019
3.3 Biologic Therapeutics Key Players Head office and Area Served
3.4 Key Players Biologic Therapeutics Product Solution and Service
3.5 Date of Enter into Biologic Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Biologic Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Biologic Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Biologic Therapeutics Market Size by Application (2015-2020)
5.2 Global Biologic Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Biologic Therapeutics Market Size (2015-2020)
6.2 Biologic Therapeutics Key Players in North America (2019-2020)
6.3 North America Biologic Therapeutics Market Size by Type (2015-2020)
6.4 North America Biologic Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Biologic Therapeutics Market Size (2015-2020)
7.2 Biologic Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Biologic Therapeutics Market Size by Type (2015-2020)
7.4 Europe Biologic Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Biologic Therapeutics Market Size (2015-2020)
8.2 Biologic Therapeutics Key Players in China (2019-2020)
8.3 China Biologic Therapeutics Market Size by Type (2015-2020)
8.4 China Biologic Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Biologic Therapeutics Market Size (2015-2020)
9.2 Biologic Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Biologic Therapeutics Market Size by Type (2015-2020)
9.4 Japan Biologic Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Biologic Therapeutics Market Size (2015-2020)
10.2 Biologic Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biologic Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Biologic Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Biologic Therapeutics Market Size (2015-2020)
11.2 Biologic Therapeutics Key Players in India (2019-2020)
11.3 India Biologic Therapeutics Market Size by Type (2015-2020)
11.4 India Biologic Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Biologic Therapeutics Market Size (2015-2020)
12.2 Biologic Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Biologic Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Biologic Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Biologic Therapeutics Introduction
13.1.4 Pfizer Revenue in Biologic Therapeutics Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Novartis Global
13.2.1 Novartis Global Company Details
13.2.2 Novartis Global Business Overview
13.2.3 Novartis Global Biologic Therapeutics Introduction
13.2.4 Novartis Global Revenue in Biologic Therapeutics Business (2015-2020)
13.2.5 Novartis Global Recent Development
13.3 AstraZeneca
13.3.1 AstraZeneca Company Details
13.3.2 AstraZeneca Business Overview
13.3.3 AstraZeneca Biologic Therapeutics Introduction
13.3.4 AstraZeneca Revenue in Biologic Therapeutics Business (2015-2020)
13.3.5 AstraZeneca Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Biologic Therapeutics Introduction
13.4.4 Merck Revenue in Biologic Therapeutics Business (2015-2020)
13.4.5 Merck Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview
13.5.3 GlaxoSmithKline Biologic Therapeutics Introduction
13.5.4 GlaxoSmithKline Revenue in Biologic Therapeutics Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
13.6 Aurobindo Pharma
13.6.1 Aurobindo Pharma Company Details
13.6.2 Aurobindo Pharma Business Overview
13.6.3 Aurobindo Pharma Biologic Therapeutics Introduction
13.6.4 Aurobindo Pharma Revenue in Biologic Therapeutics Business (2015-2020)
13.6.5 Aurobindo Pharma Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Biologic Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Biologic Therapeutics Revenue
Table 3. Ranking of Global Top Biologic Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biologic Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Vaccines
Table 6. Key Players of Blood Products
Table 7. Key Players of Allergenic Extracts
Table 8. Key Players of Human Cells and Tissues
Table 9. Key Players of Gene Therapies
Table 10. Key Players of Protein
Table 11. Key Players of Cellular Therapies
Table 12. Key Players of Xenotransplantation Products
Table 13. Global Biologic Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Biologic Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Biologic Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Biologic Therapeutics Market Share by Regions (2015-2020)
Table 17. Global Biologic Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Biologic Therapeutics Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Biologic Therapeutics Market Growth Strategy
Table 23. Main Points Interviewed from Key Biologic Therapeutics Players
Table 24. Global Biologic Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 25. Global Biologic Therapeutics Market Share by Players (2015-2020)
Table 26. Global Top Biologic Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Therapeutics as of 2019)
Table 27. Global Biologic Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Biologic Therapeutics Product Solution and Service
Table 30. Date of Enter into Biologic Therapeutics Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Biologic Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 33. Global Biologic Therapeutics Market Size Share by Type (2015-2020)
Table 34. Global Biologic Therapeutics Revenue Market Share by Type (2021-2026)
Table 35. Global Biologic Therapeutics Market Size Share by Application (2015-2020)
Table 36. Global Biologic Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. Global Biologic Therapeutics Market Size Share by Application (2021-2026)
Table 38. North America Key Players Biologic Therapeutics Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Biologic Therapeutics Market Share (2019-2020)
Table 40. North America Biologic Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. North America Biologic Therapeutics Market Share by Type (2015-2020)
Table 42. North America Biologic Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. North America Biologic Therapeutics Market Share by Application (2015-2020)
Table 44. Europe Key Players Biologic Therapeutics Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Biologic Therapeutics Market Share (2019-2020)
Table 46. Europe Biologic Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Biologic Therapeutics Market Share by Type (2015-2020)
Table 48. Europe Biologic Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Biologic Therapeutics Market Share by Application (2015-2020)
Table 50. China Key Players Biologic Therapeutics Revenue (2019-2020) (Million US$)
Table 51. China Key Players Biologic Therapeutics Market Share (2019-2020)
Table 52. China Biologic Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. China Biologic Therapeutics Market Share by Type (2015-2020)
Table 54. China Biologic Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. China Biologic Therapeutics Market Share by Application (2015-2020)
Table 56. Japan Key Players Biologic Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Biologic Therapeutics Market Share (2019-2020)
Table 58. Japan Biologic Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Biologic Therapeutics Market Share by Type (2015-2020)
Table 60. Japan Biologic Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Biologic Therapeutics Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Biologic Therapeutics Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Biologic Therapeutics Market Share (2019-2020)
Table 64. Southeast Asia Biologic Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Biologic Therapeutics Market Share by Type (2015-2020)
Table 66. Southeast Asia Biologic Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Biologic Therapeutics Market Share by Application (2015-2020)
Table 68. India Key Players Biologic Therapeutics Revenue (2019-2020) (Million US$)
Table 69. India Key Players Biologic Therapeutics Market Share (2019-2020)
Table 70. India Biologic Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. India Biologic Therapeutics Market Share by Type (2015-2020)
Table 72. India Biologic Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. India Biologic Therapeutics Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Biologic Therapeutics Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Biologic Therapeutics Market Share (2019-2020)
Table 76. Central & South America Biologic Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Biologic Therapeutics Market Share by Type (2015-2020)
Table 78. Central & South America Biologic Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Biologic Therapeutics Market Share by Application (2015-2020)
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Product
Table 83. Pfizer Revenue in Biologic Therapeutics Business (2015-2020) (Million US$)
Table 84. Pfizer Recent Development
Table 85. Novartis Global Company Details
Table 86. Novartis Global Business Overview
Table 87. Novartis Global Product
Table 88. Novartis Global Revenue in Biologic Therapeutics Business (2015-2020) (Million US$)
Table 89. Novartis Global Recent Development
Table 90. AstraZeneca Company Details
Table 91. AstraZeneca Business Overview
Table 92. AstraZeneca Product
Table 93. AstraZeneca Revenue in Biologic Therapeutics Business (2015-2020) (Million US$)
Table 94. AstraZeneca Recent Development
Table 95. Merck Company Details
Table 96. Merck Business Overview
Table 97. Merck Product
Table 98. Merck Revenue in Biologic Therapeutics Business (2015-2020) (Million US$)
Table 99. Merck Recent Development
Table 100. GlaxoSmithKline Company Details
Table 101. GlaxoSmithKline Business Overview
Table 102. GlaxoSmithKline Product
Table 103. GlaxoSmithKline Revenue in Biologic Therapeutics Business (2015-2020) (Million US$)
Table 104. GlaxoSmithKline Recent Development
Table 105. Aurobindo Pharma Company Details
Table 106. Aurobindo Pharma Business Overview
Table 107. Aurobindo Pharma Product
Table 108. Aurobindo Pharma Revenue in Biologic Therapeutics Business (2015-2020) (Million US$)
Table 109. Aurobindo Pharma Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologic Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Vaccines Features
Figure 3. Blood Products Features
Figure 4. Allergenic Extracts Features
Figure 5. Human Cells and Tissues Features
Figure 6. Gene Therapies Features
Figure 7. Protein Features
Figure 8. Cellular Therapies Features
Figure 9. Xenotransplantation Products Features
Figure 10. Global Biologic Therapeutics Market Share by Application: 2020 VS 2026
Figure 11. Rheumatoid Arthritis Case Studies
Figure 12. Anemia Case Studies
Figure 13. Cancer Case Studies
Figure 14. Diabetes Case Studies
Figure 15. Others Case Studies
Figure 16. Biologic Therapeutics Report Years Considered
Figure 17. Global Biologic Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 18. Global Biologic Therapeutics Market Share by Regions: 2020 VS 2026
Figure 19. Global Biologic Therapeutics Market Share by Regions (2021-2026)
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Biologic Therapeutics Market Share by Players in 2019
Figure 22. Global Top Biologic Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Therapeutics as of 2019
Figure 23. The Top 10 and 5 Players Market Share by Biologic Therapeutics Revenue in 2019
Figure 24. North America Biologic Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Europe Biologic Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. China Biologic Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Japan Biologic Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Southeast Asia Biologic Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. India Biologic Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Central & South America Biologic Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Bottom-up and Top-down Approaches for This Report
Figure 32. Data Triangulation
Figure 33. Key Executives Interviewed
生物学的治療薬の世界市場（～2026年） Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural s…- プラズマ治療薬の世界市場（～2026年） Plasma, pale yellow in color, is the component of the blood. To calculate the market size, the report considers revenue generated from the sales of branded therapies derived from the various fractions of plasma such as albumin, immunoglobulins, coagulation factors, hyperimmune globulins, and A1PI. M…
- 生物学用シングルユース技術の世界市場（～2026年） Single-use technologies are widely used in the biotherapeutic market to reduce risk and improve operational efficiencies. Rising awareness about therapeutic applications of biotherapeutics is a key driver for the global single-use technologies market. Market Analysis and Insights: Global Single-Use …
- 自家幹細胞ベース治療法の世界市場（～2026年） Market Analysis and Insights: Global Autologous Stem Cell Based Therapies Market The global Autologous Stem Cell Based Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Autologous Stem Cell Based Therapies Scop…
- 変形性関節症再生治療の世界市場（～2026年） Osteoarthritis is a type of joint disease that results from breakdown of joint cartilage and underlying bone. The increasing incidence of osteoarthritis is expected to drive the regenerative therapies for osteoarthritis market. Market Analysis and Insights: Global Regenerative Therapies for Osteoart…